Log In
Print
BCIQ
Print
Print this Print this
 

Avonex, Interferon beta-1a

  Manage Alerts
Collapse Summary General Information
Company Biogen Idec Inc.
DescriptionInterferon (IFN) beta-1a
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionImmune modulation
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS); Treat primary progressive multiple sclerosis (PPMS); Treat relapsing multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation

Partner

UCB Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today